One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care

Launched by UNIVERSITY OF OSLO · Feb 26, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to test patients who come to emergency primary care with chest pain. Chest pain can be caused by different issues, and it’s important to quickly determine if it’s due to a serious heart problem called acute myocardial infarction (AMI). Traditionally, testing for a substance called troponin in the blood, which helps identify heart damage, has only been done in hospitals. However, this trial will use a new point-of-care test that can measure troponin levels right in the clinic, making it easier and faster to assess patients.

The study will involve about 2,500 patients over 1.5 years, focusing on those aged 18 and older who are experiencing non-traumatic acute chest pain. If a doctor requests troponin testing, they may be eligible to participate. Throughout the trial, participants can expect to be monitored for their chest pain and overall well-being, and they will be asked to fill out questionnaires about their quality of life and any anxiety they may feel. The goal is to improve how chest pain is managed in emergency settings, reduce unnecessary hospital visits, and enhance patient care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients (18+ years) with non-traumatic acute chest pain presenting in emergency primary care
• • Troponin testing requested by the treating physician
• Exclusion Criteria:
• • Acute STEMI (direct hospital referral required)
• • Haemodynamically unstable (direct hospital referral required)
• • Not able to provide written, informed consent (i.e., due to time restraints, language barriers, impaired cognitive function, or other reasons)